Bladder Cancer Tissue Array of 66 Tissue Samples |
| Home >> Welcome to Pantomics Price List Download |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
Dedicated facility |
Catalog# BLC661 - Human bladder cancer tissue array
| Lot# | Cores | Size | Cut | Format | QA/QC | Price 1Slide |
Price Pack5 |
| BLC66101 | 66 | 1.5mm | 4um | 8X9 | H&E, IHC anti-Vimentin/Cytokeratin | $150 | $600 |
|
Order:
sales@pantomics.com
or call
1-415-863-2380,
Form:
Word
or
PDF;
PDF data |
|||||||
|
Recommended applications:
For Research use only. RNA or protein bladder cancer/non-tumor tissue profiling using IHC or ISH;
Antibody characterization. Description: Bladder cancer tissue array, 66 cores including 29 cases of bladder cancers and 4 cases of uninvolved bladder tissues in duplicates. All the tissues were from surgical resection. They were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. Each slide has >95% tissue core retention. |
 |
|
Array |
Sex |
Age |
Anatomic |
Histology |
Grade |
Stage (TNM) |
Image |
|
A1,B1 |
71 |
M |
Bladder |
Normal |
|
|
|
|
A2,B2 |
59 |
M |
Bladder |
Normal |
|
|
|
|
A3,B3 |
65 |
M |
Bladder |
Chronic cystitis |
|
|
|
|
A4,B4 |
51 |
F |
Bladder |
Chronic cystitis |
|
|
|
|
A5,B5 |
71 |
M |
Bladder |
Squamous cell carcinoma |
I |
T1N0M0 |
|
|
A6,B6 |
60 |
M |
Bladder |
Squamous cell carcinoma |
I |
T2N0M0 |
|
|
A7,B7 |
76 |
M |
Bladder |
Adenocarcinoma |
II |
T2N0M0 |
|
|
A8,B8 |
50 |
M |
Bladder |
Adenocarcinoma |
II |
T2N0M0 |
|
|
A9,B9 |
68 |
M |
Bladder |
Adenocarcinoma |
III |
T2N0M0 |
|
|
C1,D1 |
74 |
F |
Bladder |
Adenocarcinoma |
III |
T2N0M0 |
|
|
C2,D2 |
27 |
M |
Bladder |
Transitional cell carcinoma |
I |
TisN0M0 |
|
|
C3,D3 |
50 |
M |
Bladder |
Transitional cell carcinoma |
I |
T1N0M0 |
|
|
C4,D4 |
49 |
F |
Bladder |
Transitional cell carcinoma |
I |
T1N0M0 |
|
|
C5,D5 |
67 |
M |
Bladder |
Transitional cell carcinoma |
I |
T1N0M0 |
|
|
C6,D6 |
51 |
F |
Bladder |
Transitional cell carcinoma |
I |
T1N0M0 |
|
|
C7,D7 |
57 |
M |
Bladder |
Transitional cell carcinoma |
I |
T1N0M0 |
|
|
C8,D8 |
47 |
M |
Bladder |
Transitional cell carcinoma |
II |
T2N0M0 |
|
|
C9,D9 |
54 |
M |
Bladder |
Transitional cell carcinoma |
II |
T2N0M0 |
|
|
E1,F1 |
45 |
M |
Bladder |
Transitional cell carcinoma |
II |
T1N0M0 |
|
|
E2,F2 |
74 |
M |
Bladder |
Transitional cell carcinoma |
II |
T2N0M0 |
|
|
E3,F3 |
51 |
M |
Bladder |
Transitional cell carcinoma |
II |
T1N0M0 |
|
|
E4,F4 |
80 |
M |
Bladder |
Transitional cell carcinoma |
II |
T2N0M0 |
|
|
E5,F5 |
53 |
F |
Bladder |
Transitional cell carcinoma |
II |
T1N0M0 |
|
|
E6,F6 |
37 |
M |
Bladder |
Transitional cell carcinoma |
II |
T2N0M0 |
|
|
E7,F7 |
55 |
M |
Bladder |
Transitional cell carcinoma |
II |
T4N2MX |
|
|
E8,F8 |
52 |
M |
Bladder |
Transitional cell carcinoma |
II |
T1N0M0 |
|
|
E9,F9 |
78 |
M |
Bladder |
Transitional cell carcinoma |
III |
T1N0M0 |
|
|
G1,H1 |
64 |
M |
Bladder |
Transitional cell carcinoma |
III |
T3N2M1 |
|
|
G2,H2 |
70 |
M |
Bladder |
Transitional cell carcinoma |
III |
T2N0M0 |
|
|
G3,H3 |
61 |
M |
Bladder |
Transitional cell carcinoma |
III |
T2N0M0 |
|
|
G4,H4 |
61 |
M |
Bladder |
Transitional cell carcinoma |
III |
T1N0M0 |
|
|
G5,H5 |
39 |
F |
Bladder |
Transitional cell carcinoma |
III |
T2N0M0 |
|
|
G6,H6 |
30 |
M |
Bladder |
Sarcoma |
|
T2N0M0 |
|
-------------------------------------------------------------------------------------------------
All Products
|
Ordering Information
|
Privacy Policy
Copyright © 2004-2005,
Pantomics, Inc.
457 Mariposa Street, San Francisco, CA
94107, USA.
Tel: 415-863-2380